This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Looking for ways to monetize skills quickly? Turn your talents into cash and start earning today with these strategies.
17,417 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
In March 2026, the drug stock landscape blends steady demand with ongoing innovation. This article highlights three c...
Oil rose past $100 per barrel as tensions involving Iran added a geopolitical layer to markets. Yet the S&P 500 showe...
Bitcoin is notoriously volatile, but history shows recurring recovery patterns after big crashes. This article explai...
Have tech stocks finally run out of road? This data-driven exploration breaks down valuations, growth drivers, and ho...
Gas costs have ticked higher, but household responses split by income and city. The investing world watches how these...
Hyped up rare-earth plays attract attention, but many stumble before they mine. This guide breaks down how to assess ...
DeFi endured its worst April in over a year, with hundreds of millions lost to hacks. The sector now faces a shift to...
Artificial intelligence quarterly earnings are changing how investors digest company reports. This guide explains the...
Investors piled into Nextpower after strong 2026 results and a strategic acquisition. This article breaks down the ca...
A papal address warns of a spiraling risk as AI arms development accelerates, prompting markets to reassess risk, ass...
A small AI stock makes a big move. SoundHound AI just released a pivotal update that could affect its 2027 outlook an...